jsmc-10154

IN-HOSPITAL COMPLICATIONS AND OUTCOME OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION IN SULAIMANI CORONARY CARE UNIT

Amanj Abubakr Khaznadar a and Pishtiwan Hussain Qadir b

a Department of Medicine, College of Medicine, University of Sulaimani. 

b Kurdistan Board Candidate, Shahid HemnTeaching Hospital for Medical Diseases. 

Submitted: 17/2/2018; Accepted: 15/5/2018; Published 1/8/2018

DOI Link: https://doi.org/10.17656/jsmc.10154 

ABSTRACT

Background 

Complications following acute myocardial infarction started to decrease in the past three decades after development of primary percutaneous coronary intervention and thrombolytic therapy, beside many other antiplatelet medications; however complications following acute myocardial infarction still is a major concern in the developing countries.

Objectives 

To detect complications and mortality that follow acute myocardial infarction during hospitalization.

Methods and study design

An observational study, consecutive patients (n=120) with the diagnosis of acute myocardial infarction admitted to the Sulaimani coronary care unit from June 2017 to February 2018 were included in this study, the in-hospital mortality and complications were recorded and analyzed.

Results

The mean age of populations in this study was 61.39±10.36 years, there were (70%) males and (30%) females, 35% of patients were smokers, 47.5% of patients had hypertension, 35% of patients had diabetes mellitus, anterior wall infarctions was present in (41.7%) of patients, while inferior wall infarction was present in (34.2%) of patients, (27.5%) of patients received thrombolytic therapy, while (54.2%) of patients received primary percutaneous coronary intervention for revascularization, 3.3% of them died during hospital stay while 53.3% of them discharged from hospital in stable condition after staying one to two days in hospital. Left ventricular dysfunction was found in (20.7%) of patients while (13.3%) develop arrhythmia and (13.3%) develop cardiogenic shock.

Conclusion

In-hospital mortality rate of acute ST segment elevation myocardial infarction in this study was 3.3% which is comparable with studies from the western countries and India, this low rate of mortality belongs to high rate of revascularizations (percutaneous coronary intervention and thrombolytic.

KEYWORDS

Acute myocardial infarction, In-hospital complications and mortality, Sulaimani Coronary Care Unit.

References 

1. White HD, French JK, Hamer AW, et al. Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy. J Am Coll Cardiol 1995; 25:218–223.

2. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993; 329:1615–1622.

3. White HD, Cross DB, Elliott JM, Norris RM, Yee TW. Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction. Circulation 1994; 89:61–67.

4.  The APEX AMI Investigators. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA 2007; 297:43–51. 

5.  Assali AR, Iakobishvili Z, Zafrir N, et al. Characteristics and clinical outcomes of patients with cardiogenic shock complicating acute myocardial infarction treated by emergent coronary angioplasty. Int J Cardiovasc Intervent 2005; 7:193–198.

6.  Hasdai D, Topol EJ, Kilaru R, et al. Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from four international fibrinolytic therapy trials. Am Heart J 2003; 145:73–79.

7.  Menon V, White H, LeJemtel T, Webb JG, Sleeper LA, Hochman JS. The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. J Am Coll Cardiol Sep 2000; 36(3 suppl A):1071–1076

8. Tanimoto T, Imanishi T, Kitabata H, et al. Prevalence and clinical signifcance of papillary muscle infarction detected by late gadoliniumenhanced magnetic resonance imaging in patients with ST-segment elevation myocardial infarction. Circulation. 2010;122:2281–7.

9.  Yosefy C, Beeri R, Guerrero JL, et al. Mitral regurgitation after anteroapical myocardial infarction: new mechanistic insights. Circulation. 2011;123:1529–36.

10.  Tepe NA, Edmunds LH Jr. Operation for acute postinfarction mitral insuffciency and cardiogenic shock. J Thorac Cardiovasc Surg. 1985;89:525–30.

11. Topaz O, Taylor AL. Interventricular septal rupture complicating acute myocardial infarction: from pathophysiologic features to the role of invasive and noninvasive diagnostic modalities in current management. Am J Med. 1992;93:683–8

12. Lopes RD, Elliott LE, White HD, et al. Antithrombotic therapy and outcomes of patients with atrial fbrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. Eur Heart J. 2009;30:2019–28.

13.  Newby KH, Pisanó E, Krucoff MW, et al. Incidence and clinical relevance of the occurrence of bundle-branch block in patients treated with thrombolytic therapy. Circulation. 1996;94:2424–8.

14. Imazio M, Negro A, Belli R, et al. Frequency and prognostic significance of pericarditis following acute myocardial infarction treated by primary percutaneous coronary intervention. Am J Cardiol. 2009;103:1525–9

15. Figueras J, Juncal A, Carballo J, et al. Nature and progression of pericardial effusion in patients with a frst myocardial infarction: relationship to age and free wall rupture. Am Heart J. 2002;144:251–8.

16. Figueras J, Barrabés JA, Serra V, et al. Hospital outcome of moderate to severe pericardial effusion complicating ST-elevation acute myocardial infarction. Circulation. 2010;122:1902–9.

17. Steg AG, Goldberg RJ, Gore JM, et al. Baseline characteristics, management practices and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol. 2002;90:358e363.

18. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. N Eng J Med. 1997;337:1118e1123.

19. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med. 1997;336:1621e1628.

20. Fox KA, Cokkinos DV, Deckers J, Keil J, Maggioni A, Steg G. A pan-European survey of acute coronary syndromes. European Network for Acute Coronary Treatment (ENACT) study. Eur Heart J. 2000;21:1440e1449

21. Hiremath JS. Future of thrombolytic therapy  an Indian context. JAPI. 2011;59:49e50.

22. The GUSTO-I Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673e682.

23. Capewell S, Livingston BM, Maclntyre K, et al. Trends in casefatality in 117; 718 patients admitted with acute myocardial infarction in Scotland. Eur Heart J. 2000;21:1833e1840.

24. Gottwik M, Zahn R, Schiele R, et al. Differences in treatment and outcome of patients with acute myocardial infarction admitted to hospitals with compared to without departments of cardiology; results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction(MITRA 1þ2) Registries and the Myocardial Infarction Registry (MIR). Eur Heart J. 2001;22:1794e1801

25. Steinberg BA, Moghbeli N, Buros J. Global outcomes of STelevation myocardial infarction: comparisons’ of the enoxaparin and thrombolysis reperfusion for acute myocardial infarction treatment-thrombolysis in myocardial infarction study 25 (ExTRACT-TIMI 25) registry and trial. Ann Heart J. 2007;154:54e61. 

26.  Redfors B, Angeras O, Ramunddal T, et al. 17-year trends in incidence and prognosis of cardiogenic shock in patients with acute myocardial infarction in western Sweden. Int J Cardiol 2015; 185: 256-62.

27.  Awad HH, Anderson FA, Jr., Gore JM, Goodman SG, Goldberg RJ. Cardiogenic shock complicating acute coronary syndromes: insights from the Global Registry of Acute Coronary Events. Am Heart J 2012; 163: 963-71.

28. Garcia Aurelio M, Cohen Arazi H, Higa C, et al. Infarto agudo de miocardio con supradesnivel persistente del segmento ST. Registro multicéntrico SCAR (Síndromes Coronarios Agudos en Argentina) de la Sociedad Argentina de Cardiología. Rev Argent Cardiol 2014; 82: 259-67.

29. Holmes DR, Jr., Berger PB, Hochman JS, et al. Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation 1999;100: 2067-73.

30. Spencer FA, Meyer TE, Gore JM, Goldberg Rj. Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure: the National Registry of Myocardial Infarction. Circulation. 2002;105:2605e2610

31. Jose V, Gupta S. Mortality and morbidity of acute ST segment elevation MI in current era. Indian Heart J. 2004;56:210e214.

32. Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillation in acute myocardial infarction: asystematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009;30:1038–1045. [PubMed: 19109347]

33. Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ, Ohman EM. Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-III trial. Card Electrophysiol Rev. 2003; 7:201–207. [PubMed: 14739713]

34. GUSTO-I Investigators: An international randomized trial comparing four thrombolytic strategies for AMI. N Engl J Med 1993;329:673–682.

35. Wilhelmsson C, Vedin JA, Elmfeldt D, et al. Smoking and myocardial infarction. Lancet. 1975;1:415–20. [PubMed: 48609

36. Andrikopoulos GK, Richter DJ, Dilaveris PE, et al. In-hospital mortality of habitual cigarette smokers after acute myocardial infarction; the “smoker’s paradox” in a countrywide study. Eur Heart J. 2001; 22:776–84. [PubMed: 11350110]

37.  Kang SH, Suh JW, Choi DJ, et al. Cigarette smoking is paradoxically associated with low mortality risk after acute myocardial infarction. Nicotine Tob Res. 2013; 15:1230–8. [PubMed: 23231825]

Full Text

 © The Authors, published by University of Sulaimani, College of Medicine

This work is licensed under a Creative Commons Attribution 4.0 International License.